CDA CPG logo menu
  • Become a Member
  • Order Resources
  • Home
  • About
  • Contact
  • DONATE

The Canadian Diabetes Association has become Diabetes Canada*

CDA CPG logo
  • Guidelines
  • 2023 Updates
  • 2022 Updates
  • 2021 Updates
  • 2020 Updates
  • Full Guidelines
  • Appendices
  • Quick Reference Guide
  • Slides
  • Videos
  • Get the App
  • Key Messages
  • Reduce Complications
  • Keep People Safe
  • Self-management
  • For Health-Care Providers
  • Tools & Resources
  • Webinars
  • Case Studies
  • For People with Diabetes
  • Financial Support and Services
  • Tools & Resources
  • Videos
  • Other Languages
  • Ressources françaises
  • 中文資源
  • Links
  • Terms of Use
  • Citations
  • Site Map
  • orders.diabetes.ca
  • diabetes.ca
  • diabetes365.ca
  • LinedInFacebookTwitterInstagramYouTube
Print

Self Management Education

Medication Sheets

Medication sheets have been created to provide more information on diabetes medications that people with diabetes may be taking. The medication sheets have been organized by types of medications.

  • Alpha-glucosidase inhibitor: Acarbose (Glucobay®)
  • Biguanide: Metformin (Glucophage®), Long Acting Metformin (Glumetza®)
  • DPP-4 inhibitor: Linagliptin (Trajenta™), Saxagliptin (Onglyza®) Sitagliptin (Januvia®), Combination agents: Linagliptin/metformin (Jentadueto®), Saxagliptin/metformin (Komboglyze™), Sitagliptin/metformin (Janumet®)
  • GLP-1 receptor agonist: Exenatide (Byetta®), Liraglutide (Victoza®)
  • Non-sulfonylurea insulin secretagogue: Nateglinide (Starlix®), Repaglinide (Gluconorm®)
  • SGLT2 Inhibitors: Canagliflozin (Invokana®), Dapagliflozin (Forxiga™), Empagliflozin (Jardiance™)
  • Sulfonylurea insulin secretagogue: Glicazide (Diamicron®), Glimepiride (Amaryl®), Glyburide (DiaBeta®)

*The Canadian Diabetes Association is the registered owner of the name Diabetes Canada. All content on guidelines.diabetes.ca, CPG Apps and in our online store remains exactly the same. For questions, contact communications@diabetes.ca.